Back to Treatments

Treatment

Voxelotor

1
Conditions
25
Trials
1,500
Participants
70%
Average Safety

Condition Evidence

Sickle cell disorders

25 trials · 1,500 participants

68% effectiveness · 70% safety
Voxelotor | DFDA